Success at The Pharmacy Show

pre-Conceive Success Pharmacy Show 2016

Pillar Healthcare has just enjoyed a massively successful trip to the NEC in Birmingham for The Pharmacy Show – the UK’s largest conference for community pharmacy professionals and their industry.

The highlight of the trip was undoubtedly how Pillar Healthcare’s innovative fertility supplement pre-Conceive was announced as winner in the ‘Best Supplement & Herbal’ category in the Product Awards held there. There were eight other nominations for the award, including brands that are longer-established and are of wider use amongst the public, but pre-Conceive was voted the winner thanks to its ground-breaking formula that has been clinically proven to improve key fertility parameters in both women and men.

Pillar Healthcare’s Managing Director, Mark Whitney, was overjoyed with the success.

It is always great to be nominated for such a prestigious award. Looking at the calibre of the other companies and products pre-Conceive was nominated with, it makes the success all the more special. It is always great to get the recognition for the hard work that goes in to creating and developing a product. Hopefully, pre-Conceive can go on to help more couples conceive naturally or with assisted reproduction…

he said.

Pillar Healthcare and pre-Conceive had already been listed as one of the ‘Must-See’ exhibitors at The Pharmacy Show, which is attended by thousands. This is due to how the company and product exactly fit the ethos of the Show – to showcase new solutions for the pharmacy sector.

Being both a ‘Must-See’ and an award winner meant the Pillar Healthcare stand was visited by a large number of pharmacy professionals during the two-day exhibition, and Pillar Healthcare is now looking forward to further expanding the availability of pre-Conceive in the UK.

Unsuccessful IVF ‘may affect women’s heart health’

womensheartissues

Medical News Today has reported research from Canada that suggests women who have undergone unsuccessful IVF cycles may be at greater risk of heart failure and stroke.

The research focuses on the short-term risk to such women (the study involved a follow-up period of 8.4 years), and notes that few studies have assessed the long-term impact of fertility therapy on heart health.

Of those who participated in the study however, it was found that women who did not become pregnant after fertility treatment were found to have a 19% greater risk of cardiovascular events, particularly stroke and heart failure.

Continue reading

A husband’s fertility journey

malefertilityissues

There was an interesting Q&A article in The New York Times, where a female writer who is currently undergoing IVF treatment posed a series of questions to her husband.

The questions addressed such issues as seeking a male perspective on fertility issues, how their fertility journey has changed their relationship, and how men and women may handle fertility issues differently.

These are feelings and emotions that we know are shared by many couples undergoing IVF or other fertility treatments, and so we thought we’d share the article here.

Continue reading

Worldwide decrease in sperm quality

sperm 640

An article in The New York Times has highlighted concerns regarding the quality of sperm produced by young men today, quoting research that as much as 90 per cent of sperm may be misshapen.

Common chemicals used in plastics, cosmetics, couches, pesticides and countless other products are suggested as one cause of the decrease in sperm quality, while other causes may be biological problems and an increase in the incidence of testicular cancer.

Overall, fears are beginning to rise that birth rates may drop because of the issue, and that ultimately, we could even face a human reproductive crisis.

Continue reading

Should Lifestyle Advice Be a Greater Part of Fertility Treatment? The experts say ‘Yes!’

lifestyle

In the United States, the ‘Practice Committee of the American Society for Reproductive Medicine’, in collaboration with the ‘Society for Reproductive Endocrinology and Infertility’, produced a report on other factors concerning fertility and conception.

Infertile couples often end up undergoing some form of assisted reproductive technology (ART) to help them start a family. As public awareness increases, many couples think of ART as a simple alternative, should they fail to conceive on their own. However, a study published in the online journal, ‘BMJ Open’, stated that many claims made by UK fertility clinics about the benefits of treatments beyond standard IVF procedures are not backed up by evidence.

Continue reading

pre-Conceive now available at Amazon

amazon

Pillar Healthcare is proud to announce that its ground-breaking and all-natural fertility supplement for both women and men, pre-Conceive, is now available for purchase on Amazon.

The listing with the world’s largest online retailer is further evidence of pre-Conceive’s increasing international renown, and makes it more readily available to people who may not have previously been aware of it or tried it.

Continue reading

Further evidence of the power of pre-Conceive

morphology

Ongoing analysis of data collected during our pioneering first-ever clinical study in Europe into an all-natural fertility supplement has yielded further encouraging news for male partners in couples who are struggling to conceive.

Our research team has found that sperm morphology was improved in 66% of male participants in the study – therefore giving them a greater chance of fathering a child.

Continue reading

PCOS often goes undiagnosed

misdiagnosis

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder – and most common cause of infertility – affecting 9 to 18 percent of women around the world.

Despite the prevalence of the complex and chronic condition, one-third of women diagnosed with PCOS saw at least three health professionals over the course of two years before receiving a diagnosis, according to a study from the Perelman School of Medicine at the University of Pennsylvania.

The study, published in the Journal of Clinical Endocrinology & Metabolism, is the largest to date examining time to diagnosis, and reveals what the authors say are “major gaps” in education and support for women with the condition.

Continue reading

New insight into difficulties faced by some women in becoming pregnant

woman with test

Researchers in Southampton have found new insight into why some women have difficulty in becoming pregnant.

Endometriosis is a chronic condition affecting around 10 per cent of women and is associated with chronic abdominal pain, irregular periods, and lowered fertility.

In order to become pregnant a woman must produce a mature egg. Maturation occurs in fluid-filled structures called follicles in the ovary. The mature eggs are then released to become fertilised however eggs in women who have endometriosis are affected by a very hostile uterine environment that lowers fertility. It is assumed that the egg itself, before it is released, is not affected by the endometriosis.

Continue reading